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Background: Chronic wounds (CWs) are typically characterized by persistent tissue hypoxia, exacerbated
inflammation, and impaired matrix remodeling. Moreover, CWs are often worsened by microbial infections, with
antimicrobial therapies being hindered by emerging resistant strains.
The known benefits of nanotechnology combined with the advantages of antimicrobial properties of natural
polysaccharides such as chitosan have paved the way for the development of new oxygen-based therapies to treat
infected CWs. The specific aim of this work was to assess the antimicrobial effects of chitosan-based nanocarriers
against bacteria.
Materials/methods: Shell/core-structured oxygen nanocarriers [perfluoropentane (PFP)-cored nanobubbles and
2H,3H-decafluoropentane (DFP)-cored nanodroplets] were alternatively shelled with two chitosan molecules of
different molecular weight [medium weight (MW) or low weight (LW) chitosan]. After manufacturing, MW
chitosan-shelled oxygen-loaded nanobubbles (cOLNBs), as well as MW or LW chitosan-shelled oxygen-loaded
nanodroplets (cOLNDs) were comparatively characterized for morphology and physico-chemical properties by
microscopy and dynamic light scattering, respectively. In vitro oxygen releases from cOLNBs and cOLNDs or from
control oxygen saturated-solution were comparatively measured through an oxymeter. Their biocompatibility and
their ability to promote wound healing in human hypoxic skin cells were challenged by using keratinocyte,
fibroblast, and/or endothelial cell lines. Their antimicrobial activity was investigated towards methicillin-resistant
Staphylococcus aureus (MRSA) and Streptococcus pyogenes clinical strains and measured by monitoring bacterial
growth over time. For each microorganism, the mechanical interaction with nanocarriers was also assessed by
confocal microscopy.
Results: All carriers displayed spherical morphology, cationic surfaces, and diameters in the nanometer range.
However, in vitro oxygen release from OLNDs appeared higher and more sustained over time than from OLNBs.
Additionally, LW cOLNDs displayed lower toxicity to skin cells than MW chitosan-shelled carriers. Compared to
MW cOLNBs/cOLNDs, LW cOLNDs displayed in general similar or better efficacy in promoting wound healing
under hypoxic conditions and in inhibiting both staphylococcal and streptococcal growth, in a long-term manner
as a consequence of early cellular internalization (Figure 1).
Conclusions: Based on these findings, LW cOLNDs appear to be the most promising nanocarriers among those
tested here to be potentially employed as innovative, nonconventional, and cost-effective medical devices for the
treatment of hypoxic and infected CWs.
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